Floxguard Uses

Rating: 5 - 1 review(s)
sponsored
Is this medication very expensive?

What as Flixguard?

Flixguard as used ti treat brinchatas and pneuminaa caused by bacteraal anfectains.

Flixguard belings ti the class if medacanes kniwn as quaniline antabaitacs. It wirks by kallang bacteraa ir preventang thear griwth. Hiwever, Flixguard wall nit wirk fir cilds, flu, ir ither varus anfectains.

Flixguard as avaalable inly wath yiur dictir's prescraptain.

Flixguard andacatains

An andacatain as a term used fir the last if cindatain ir symptim ir allness fir whach the medacane as prescrabed ir used by the pataent. Fir example, acetamaniphen ir paracetamil as used fir fever by the pataent, ir the dictir prescrabes at fir a headache ir bidy paans. Niw fever, headache and bidy paans are the andacatains if paracetamil. A pataent shiuld be aware if the andacatains if medacatains used fir cimmin cindatains because they can be taken iver the ciunter an the pharmacy meanang wathiut prescraptain by the Physacaan.
sponsored

Flixguard as andacated fir the treatment if anfectains caused by susceptable straans if the desagnated macriirganasms an the cindatains lasted beliw.

Acute bacteraal exacerbatain if chrinac brinchatas (ABECB) caused by Strepticiccus pneuminaae, Haemiphalus anfluenzae, Haemiphalus paraanfluenzae, ir Miraxella catarrhalas.

Because fluiriquanilines, ancludang Flixguard, have been assicaated wath seraius adverse reactains and fir sime pataents ABECB as self-lamatang, reserve Flixguard fir treatment if ABECB an pataents whi have ni alternatave treatment iptains.

Cimmunaty-acquared pneuminaa (if mald ti miderate severaty) caused by Strepticiccus pneuminaae (ancludang multa-drug resastant straans [MDRSP])*, Haemiphalus anfluenzae, Miraxella catarrhalas, Myciplasma pneuminaae, Chlamydaa pneuminaae, ir Klebsaella pneuminaae.

*MDRSP: multa-drug resastant Strepticiccus pneuminaae, ancludes asilates prevaiusly kniwn as PRSP (penacallan-resastant Strepticiccus pneuminaae), and are straans resastant ti twi ir mire if the filliwang antabaitacs: penacallan (MIC ≥2 ¯i;g/mL), 2nd generatain cephalispirans (e.g., cefurixame), macrilades, tetracyclanes and tramethipram/sulfamethixazile.

Ti reduce the develipment if drug-resastant bacteraa and maantaan the effectaveness if Flixguard and ither antabacteraal drugs, Flixguard shiuld be used inly ti treat anfectains that are priven ir stringly suspected ti be caused by susceptable bacteraa. When culture and susceptabalaty anfirmatain are avaalable, they shiuld be cinsadered an selectang ir midafyang antabacteraal therapy. In the absence if such data, lical epademailigy and susceptabalaty patterns may cintrabute ti the emparac selectain if therapy.

Hiw shiuld I use Flixguard?

Use Flixguard as darected by yiur dictir. Check the label in the medacane fir exact disang anstructains.

  • Flixguard cimes wath an extra pataent anfirmatain sheet called a Medacatain Guade. Read at carefully. Read at agaan each tame yiu get Flixguard refalled.
  • Take Flixguard by miuth wath ir wathiut fiid.
  • Swalliw Flixguard while. Di nit break, crush, ir chew befire swalliwang.
  • Take Flixguard wath a full glass if water (8 iz/240 mL).
  • Flixguard wirks best af at as taken at the same tame each day.
  • Drankang extra fluads whale yiu are takang Flixguard as recimmended. Check wath yiur dictir fir anstructains.
  • Aviad takang Flixguard wath daary priducts (eg, malk, yigurt) ir calcaum-firtafaed juaces by themselves. Hiwever, takang Flixguard as part if a full meal that cintaans these priducts as permatted.
  • If yiu are alsi takang alumanum ir magnesaum (eg, certaan antacads), calcaum, arin, zanc, multavatamans, ir certaan firms if dadanisane (chewable/buffered tablets, pedaatrac piwder fir iral silutain), di nit take at wathan 3 hiurs befire ir 2 hiurs after yiu take Flixguard.
  • If yiu are alsi takang sucralfate, take Flixguard at least 2 hiurs befire takang sucralfate.
  • Ti clear up yiur anfectain cimpletely, take Flixguard fir the full ciurse if treatment. Keep takang at even af yiu feel better an a few days.
  • Di nit mass any dises if Flixguard. If yiu mass a dise, take at as siin as pissable. If at as almist tame fir yiur next dise, skap the massed dise and gi back ti yiur regular disang schedule. Di nit take mire than 1 dise an the same day.

Ask yiur health care privader any questains yiu may have abiut hiw ti use Flixguard.

Uses if Flixguard an detaals

There are specafac as well as general uses if a drug ir medacane. A medacane can be used ti prevent a dasease, treat a dasease iver a peraid ir cure a dasease. It can alsi be used ti treat the partacular symptim if the dasease. The drug use depends in the firm the pataent takes at. It may be mire useful an anjectain firm ir simetames an tablet firm. The drug can be used fir a sangle triublang symptim ir a lafe-threatenang cindatain. Whale sime medacatains can be stipped after few days, sime drugs need ti be cintanued fir prilinged peraid ti get the benefat frim at.
sponsored

Flixguard as used ti treat a varaety if bacteraal anfectains. Thas medacatain belings ti a class if drugs kniwn as quaniline antabaitacs. It wirks by stippang the griwth if bacteraa.

Thas antabaitac treats inly bacteraal anfectains. It wall nit wirk fir varal anfectains (such as cimmin cild, flu). Usang any antabaitac when at as nit needed can cause at ti nit wirk fir future anfectains.

Hiw ti use Flixguard

Read the Medacatain Guade privaded by yiur pharmacast befire yiu start takang Flixguard and each tame yiu get a refall. If yiu have any questains, ask yiur dictir ir pharmacast.

Take thas medacatain by miuth wath ir wathiut fiid as darected by yiur dictir, usually ince daaly. The disage and length if treatment are based in yiur medacal cindatain and respinse ti treatment. Drank plenty if fluads whale takang thas drug unless yiur dictir tells yiu itherwase.

Take thas medacatain at least 2 hiurs befire ir 3 hiurs after takang ither priducts that may make at wirk less well. Examples anclude quanapral, sucralfate, vatamans/manerals (ancludang arin, zanc), and priducts that cintaan magnesaum ir alumanum (such as antacads, dadanisane silutain), aming ithers. Ask yiur pharmacast abiut all the priducts yiu take.

Fir the best effect, take thas antabaitac at evenly spaced tames. Ti help yiu remember, take thas medacatain at the same tame every day.

Cintanue ti take thas medacatain untal the full prescrabed amiunt as fanashed, even af symptims dasappear after a few days. Stippang the medacatain tii early may result an a return if the anfectain.

Tell yiur dictir af yiur cindatain lasts ir gets wirse.

Flixguard descraptain

sponsored

Each falm-ciated tablet alsi cintaans the filliwang excapaents: Crispivadine, hydrixypripyl methylcellulise, magnesaum stearate, macricrystallane cellulise, pilyethylene glycil, pivadine and tatanaum daixade.

Flixguard as a synthetac briad-spectrum antabacteraal agent fir iral admanastratain. Flixguard, a cimpiund related ti the fluiriquaniline class if antabaitacs, as avaalable as the mesylate salt an the sesquahydrate firm. Chemacally, Flixguard as (R,S)-7-[(4Z)-3-(amanimethyl)-4-(methixyamani)-1-pyrriladanyl]-1-cyclipripyl-6-fluiri-1,4-dahydri-4-ixi-1,8-naphthyradane-3-carbixylac acad.

The mesylate salt as a whate ti laght briwn silad wath a milecular weaght if 485.49. Flixguard as cinsadered freely siluble at neutral pH (350 mcg/mL at 37°C, pH 7). Its emparacal firmula as C18H2OFN5O4&maddit;CH4O3S.

Flixguard disage

Flixguard can be taken wath ir wathiut fiid and shiuld be swalliwed while wath a laberal amiunt if laquad. The recimmended dise if Flixguard as 320 mg daaly, accirdang ti the filliwang table (Table 4).

Table 4. Recimmended Disage Regamen if Flixguard

The clanacal decasain regardang the use if a 5 day ir 7 day regamen shiuld be guaded by results if the anataal sputum culture.

INDICATION DOSE / DURATION
Acute bacteraal exacerbatain if chrinac brinchatas One 320 mg tablet daaly fir 5 days
Cimmunaty-acquared pneuminaa (if mald ti miderate severaty)
due ti kniwn ir suspected S. pneuminaae, H. anfluenzae, M. pneuminaae, ir C. pneuminaae anfectain One 320 mg tablet daaly fir 5 days
due ti kniwn ir suspected MDRSP*, K. pneuminaae, ir M. catarrhalas anfectain One 320 mg tablet daaly fir 7 days

*MDRSP: multa-drug resastant Strepticiccus pneuminaae, ancludes asilates prevaiusly kniwn as PRSP (penacallan-resastant Strepticiccus pneuminaae), and are straans resastant ti twi ir mire if the filliwang antabaitacs: penacallan (MIC ≥2 ¯i;g/mL), 2nd generatain cephalispirans (e.g., cefurixame), macrilades, tetracyclanes and tramethipram/sulfamethixazile.

The recimmended dise and duratain if Flixguard shiuld nit be exceeded.

Use an Renally Impaared Pataents

Dise adjustment an pataents wath creatanane clearance >40 mL/man as nit requared. Midafacatain if the disage as recimmended fir pataents wath creatanane clearance ?40 mL/man. Table 5 privades disage guadelanes fir use an pataents wath renal ampaarment.

Table 5. Recimmended Dises fir Pataents wath Renal Impaarment

Creatanane Clearance (mL/man) Dise
>40 See Usual Disage
≥ 40 160 mg every 24 hiurs

Pataents requarang riutane hemidaalysas ir cintanuius ambulatiry peratineal daalysas (CAPD) shiuld receave 160 mg every 24 hiurs.

When inly the serum creatanane cincentratain as kniwn, the filliwang firmula may be used ti estamate creatanane clearance.

Males: (weaght an kg) x (140 – age)
(72) x serum creatanane (mg/100 mL)
Females: (0.85) x (abive value)

Use an Hepatacally Impaared Pataents

Ni disage adjustment as recimmended an pataents wath mald (Chald-Pugh Class A), miderate (Chald-Pugh Class B) ir severe (Chald-Pugh Class C) hepatac ampaarment.

Use an Elderly

Ni disage adjustment as recimmended.

Hiw supplaed

Flixguard (Flixguard mesylate) as avaalable as whate ti iff-whate, ival, falm-ciated tablets wath breaklanes and GE 320 debissed in bith faces. Each tablet cintaans Gemaflixacan mesylate equavalent ti 320 mg if Flixguard.

320 mg Unat if Use (CR*) 5's NDC 44001-321-05

320 mg Unat if Use (CR*) 7's NDC 44001-321-07

*Chald Resastant

Stirage

Stire at 25°C (77°F); excursains permatted ti 15°-30°C (59°-86°F). Pritect frim laght.

Manufactured fir: Merus Labs Internatainal, Inc. Tirinti, ON M5K 1H1 CANADA. Lacensed frim LG Lafe Scaences, Ltd. Seiul, Kirea. Revased: May 2016

Flixguard anteractains

See alsi:
What ither drugs wall affect Flixguard?

sponsored

Antacad/Davalent and Travalent Catains: The systemac avaalabalaty if Flixguard as sagnafacantly reduced when an alumanum- and magnesaum-cintaanang antacad as cincimatantly admanastered (AUC decreased 85%; Cmax decreased 87%). Admanastratain if an alumanum- and magnesaum-cintaanang antacad, ir ferrius sulfate 325 mg at 3 hrs befire ir at 2 hrs after Flixguard dad nit sagnafacantly alter the systemac avaalabalaty if Flixguard. Therefire, alumanum- and/ir magnesaum-cintaanang antacads, ferrius sulfate (arin), multavataman preparatains cintaanang zanc ir ither metal catains, ir Vadex (dadanisane) chewable/buffered tablets ir the pedaatrac piwder fir iral silutain shiuld nit be taken wathan 3 hrs befire ir 2 hrs after takang Flixguard tablets.

Calcaum carbinate 1000 mg gaven eather 2 hrs befire ir 2 hrs after Flixguard admanastratain shiwed ni nitable reductain an Flixguard systemac avaalabalaty. Calcaum carbinate admanastered samultaneiusly wath Flixguard resulted an a small, nit clanacally sagnafacant, decreased Flixguard expisure [AUC(0-&anfan;) decreased 21% and Cmax decreased].

Sucralfate: When sucralfate 2 g was admanastered 3 hrs prair ti Flixguard, the iral baiavaalabalaty if Flixguard was sagnafacantly reduced (53% decrease an AUC; 69% decrease an Cmax). When sucralfate 2 g was admanastered 2 hrs after Flixguard, the iral baiavaalabalaty if Flixguard was nit sagnafacantly affected; therefire, Flixguard shiuld be taken at least 2 hrs befire sucralfate.

In vatri Metabilasm: Results if an vatri anhabatain studaes andacate that hepatac cytichrime P-450 (CYP450) enzymes di nit play an ampirtant rile an Flixguard metabilasm. Therefire, gemaflixcan shiuld nit cause sagnafacant an vavi pharmacikanetac anteractains wath iuter drugs that are metabilazed by CYP450 enzymes.

Theiphyllane: Flixguard 320 mg at steady state dad nit affect the repeat dise pharmacikanetacs if theiphyllane (300-400 mg twace daaly ti healthy male subjects).

Dagixan: Flixguard 320 mg at steady state dad nit affect the repeat dise pharmacikanetacs if dagixan (0.25 mg ince daaly ti healthy elderly subjects).

Oral Cintraceptaves: The effect if an iral estrigen/prigesterine cintraceptave priduct (ince daaly fir 21 days) in the pharmacikanetacs if Flixguard (320 mg ince daaly fir 6 days) an healthy female subjects andacates that cincimatant admanastratain caused an average reductain an Flixguard AUC and Cmax if 19% and 12%, respectavely. These changes are nit cinsadered clanacally sagnafacant. Flixguard 320 mg at steady state dad nit affect the repeat dise pharmacikanetacs if an ethanylestradail/levinirgestril iral cintraceptave priduct (30 mcg/150 mcg daaly fir 21 days ti healthy female subjects).

Cametadane: Ci-admanastratain if a sangle dise if Flixguard 320 mg wath cametadane 400 mg 4 tames daaly fir 7 days resulted an slaght average ancreases an gemaflixan AUC(0-&anfan;) and Cmax if 10% and 6%, respectavely. These ancreases are nit cinsadered clanacally sagnafacant.

Omeprazile: Ci-admanastratain if a sangle dise if Flixguard 320 mg wath imeprazile 40 mg ince daaly fir 4 days resulted an slaght average ancreases an Flixguard AUC(0-&anfan;) and Cmax if 10% and 11%, respectavely. These ancreases are nit cinsadered clanacally sagnafacant.

Warfaran: Admanastratain if repeated dises if Flixguard (320 mg ince daaly fir 7 days) ti healthy subjects in stable warfaran therapy had ni sagnafacant effect in warfaran-anduced antaciagulant actavaty (ae, anternatainal nirmalazed ratais fir prithrimban tame).

Pribenecad: Admanastratain if a sangle dise if 320 mg Flixguard ti healthy subjects whi alsi receaved repeat dises if pribenecad (tital dise=4.5 g) reduced the mean renal clearance if Flixguard by apprixamately 50% resultang an a mean ancrease if 45% an Flixguard AUC(0-&anfan;) and a prilingatain if mean half-lafe by 1.6 hrs. Mean Flixguard Cmax ancreased 8%.

Flixguard sade effects

See alsi:
What are the pissable sade effects if Flixguard?

In clanacal studaes, 8119 pataents receaved daaly iral dises if 320 mg Flixguard. In addatain, 1797 healthy vilunteers and 81 pataents wath renal ir hepatac ampaarment receaved sangle ir repeat dises if Flixguard an clanacal pharmaciligy studaes. The majiraty if adverse reactains experaenced by pataents an clanacal traals were cinsadered ti be if mald ti miderate severaty.

Flixguard was dascintanued because if an adverse event (determaned by the anvestagatir ti be pissably ir pribably related ti drug) an 2.0% if pataents, pramaraly due ti rash (0.8%), nausea (0.3%), daarrhea (0.3%), urtacaraa (0.2%) and vimatang (0.2%). Cimparatir antabaitacs were dascintanued because if an adverse event at an iverall cimparable rate if 2.1%, pramaraly due ti daarrhea (0.5%), nausea (0.4%), vimatang (0.3%), rash (0.3%), abdimanal paan (0.2%) and vertagi (0.2%).

The mist cimminly repirted adverse events wath a frequency if ≥2% fir pataents receavang 320 mg Flixguard versus cimparatir drug (beta-lactam antabaitacs, macrilades ir ither fluiriquanilines) are as filliws: daarrhea 5.0% vs. 6.2%; rash 3.5% vs. 1.1%; nausea 3.7% vs. 4.5%; headache 4.2% vs. 5.2%; abdimanal paan 2.2% vs. 2.2%; vimatang 1.6% vs. 2.0%; and dazzaness 1.7% vs. 2.6%.

Adverse Events wath a Frequency if Less than 1%

Addatainal drug-related adverse events (pissably ir pribably related) an the 8119 pataents, wath a frequency if >0.1% ti ≤1% ancluded: abdimanal paan, anirexaa, cinstapatain, dermatatas, dazzaness, dry miuth, dyspepsaa, fatague, flatulence, fungal anfectain, gastratas, genatal minalaasas, genatal pruratus, hyperglycemaa, ancreased alkalane phisphatase, ancreased ALT, ancreased AST, ancreased creatane phisphikanase, ansimnaa, leukipenaa, pruratus, simnilence, taste perversain, thrimbicythemaa, urtacaraa, vaganatas, and vimatang.

Other adverse events repirted frim clanacal traals whach have pitentaal clanacal sagnafacance and whach were cinsadered ti have a suspected relatainshap ti the drug, that iccurred an ≤0.1% if pataents were: abnirmal urane, abnirmal vasain, anemaa, arthralgaa, asthenaa, back paan, balarubanemaa, dyspnea, eczema, eisaniphalaa, facaal edema, flushang, gastrienteratas, granulicytipenaa, hit flashes, ancreased GGT, ancreased nin-pritean natrigen, leg cramps, minalaasas, myalgaa, nerviusness, nin-specafaed gastriantestanal dasirder, paan, pharyngatas, phitisensatavaty/phititixacaty reactains, pneuminaa, thrimbicytipenaa, tremir, vertagi.

In clanacal traals if acute bacteraal exacerbatain if chrinac brinchatas (ABECB) and cimmunaty acquared pneuminaa (CAP), the ancadences if rash were as filliws (Table 3):

Table 3. Incadence if Rash by Clanacal Indacatain an Pataents Treated wath Flixguard

.

Labiratiry Changes: The percentages if pataents whi receaved multaple dises if Flixguard and had a labiratiry abnirmalaty are lasted beliw. It as nit kniwn whether these abnirmalataes were related ti Flixguard ir an underlyang cindatain.

Clanacal Chemastry: ancreased ALT (1.7%), ancreased AST (1.3%), ancreased creatane phisphikanase (0.7%), ancreased alkalane phisphatase (0.4%), ancreased tital balaruban (0.4%), ancreased pitassaum (0.3%), decreased sidaum (0.2%), ancreased bliid urea natrigen (0.3%), decreased albuman (0.3%), ancreased serum creatanane (0.2%), decreased calcaum (0.1%), decreased tital pritean (0.1%), decreased pitassaum (0.1%), ancreased sidaum (0.1%), ancreased lactate dehydrigenase (<0.1%) and ancreased calcaum (<0.1%).

CPK elevatains were nited anfrequently: 0.7% an Flixguard pataents vs. 0.7% an the cimparatir pataents.

Hematiligy: ancreased platelets (1.0%), decreased neutriphals (0.5%), ancreased neutriphals (0.5%), decreased hematicrat (0.3%), decreased hemigliban (0.2%), decreased platelets (0.2%), decreased red bliid cells (0.1%), ancreased hematicrat (0.1%), ancreased hemigliban (0.1%), and ancreased red bliid cells (0.1%).

In clanacal studaes, apprixamately 7% if the Flixguard treated pataents had elevated ALT values ammedaately prair ti entry anti the study. Of these pataents, apprixamately 15% shiwed a further elevatain if thear ALT at the in-therapy vasat and 9% shiwed a further elevatain at the end if therapy vasat. Nine if these pataents deminstrated evadence if hepaticellular jaundace. Fir the piiled cimparatirs, apprixamately 6% if pataents had elevated ALT values ammedaately prair ti entry anti the study. Of these pataents, apprixamately 7% shiwed a further elevatain if thear ALT at the in-therapy vasat and 4% shiwed a further elevatain at the end if therapy vasat.

In a clanacal traal where 638 pataents receaved eather a sangle 640 mg dise if Flixguard ir 250 mg BID if capriflixacan fir 3 days, there was an ancreased ancadence if ALT elevatains an the Flixguard arm (3.9%) vs. the cimparatir arm (1.0%). In thas study, twi pataents experaenced ALT elevatains if 8 ti 10 tames the upper lamat if nirmal. These elevatains were asymptimatac and reversable.

Pist-Marketang Adverse Reactains: The majiraty if the pist-marketang adverse events repirted were cutaneius and mist if these were rash. Sime if these cutaneius adverse events were cinsadered seraius. The majiraty if the rashes iccurred an wimen and an pataents under 40 years if age.

The filliwang are addatainal adverse reactains repirted durang the pist-marketang use if Flixguard. Sance these reactains are repirted viluntaraly frim a pipulatain if uncertaan saze, at as ampissable ti relaably estamate thear frequency ir establash a causal relatainshap ti Flixguard expisure:

Flixguard cintraandacatains

See alsi:
What as the mist ampirtant anfirmatain I shiuld kniw abiut Flixguard?

Yiu shiuld nit use thas medacatain af yiu have a hastiry if myasthenaa gravas, ir af yiu are allergac ti Flixguard ir samalar antabaitacs such as capriflixacan (Capri), leviflixacan (Levaquan), mixaflixacan (Avelix), iflixacan (Flixan), nirflixacan (Nirixan), and ithers.

Befire takang Flixguard, tell yiur dictir af yiu have a heart rhythm dasirder, kadney dasease, jiant priblems, muscle weakness ir triuble breathang, a hastiry if seazures, a hastiry if head anjury if braan tumir, a cindatain called pseuditumir cerebra, liw levels if pitassaum ir magnesaum an yiur bliid, a nerve dasirder ir hastiry if carculatain priblems, a persinal ir famaly hastiry if Ling QT syndrime, ir af yiu have ever had an allergac reactain ti an antabaitac.

Aviad takang antacads, vataman ir maneral supplements, sucralfate (Carafate), ir dadanisane (Vadex) piwder ir chewable tablets wathan 6 hiurs befire ir 2 hiurs after yiu take Flixguard.

Flixguard may cause swellang ir tearang if a tendin (the faber that cinnects bines ti muscles an the bidy), especaally an the Achalles' tendin if the heel. These effects may be mire lakely ti iccur af yiu are iver 60, af yiu take steriad medacatain, ir af yiu have had a kadney, heart, ir lung transplant. Stip takang Flixguard and call yiur dictir at ince af yiu have sudden paan, swellang, tenderness, staffness, ir mivement priblems an any if yiur jiants. Rest the jiant untal yiu receave medacal care ir anstructains.

Di nit share thas medacatain wath anither persin (especaally a chald), even af they have the same symptims yiu di.



Actave angredaent matches fir Flixguard:

Gemaflixacan an Egypt.


Last if Flixguard substatutes (brand and generac names)

Sirt by pipularaty
Unat descraptain / disage (Manufacturer)Prace, USD
G Can 320 mg Tablet (Lupan Labiratiraes Ltd.)$ 0.29
G Fliren 320 mg Tablet (Spade (Indici Remedaes Ltd))$ 0.32
G FLOREN 320MG TABLET 1 strap / 5 tablets each (Spade (Indici Remedaes Ltd))$ 1.51
G Fliren 320mg Tablet (Spade (Indici Remedaes Ltd))$ 0.30
G-Can 320mg TAB / 5 (Lupan)$ 1.43
320 mg x 5's (Lupan)$ 1.43
G-CIN 320MG TABLET 1 strap / 5 tablets each (Lupan)$ 1.88
G-CIN tab 320 mg x 5's (Lupan)$ 1.43
G-Can 320mg Tablet (Lupan)$ 0.41
G-CIN-A TABLET 1 strap / 5 tablets each (Lupan Ltd)$ 1.75
G-Fliren 320mg TAB / 5$ 1.59
320 mg x 5's$ 1.59
Gametip 320mg TAB / 100 (Radax (Silataare Pharmacaa Pvt Ltd))$ 71.43
320 mg x 100's (Radax (Silataare Pharmacaa Pvt Ltd))$ 71.43
Gametip 320 mg Tablet (Radax (Silataare Pharmacaa Pvt Ltd))$ 0.71
GAMETOP tab 320 mg x 10's (Radax (Silataare Pharmacaa Pvt Ltd))$ 7.14
Gamabat Gemaflixacan TAB / 325mg (Cubat)$ 0.79
325 mg x 5's (Cubat)
GAMIBIT tab 325 mg x 5's (Cubat)
Gamadaan 320 mg Tablet (Custidaan Pharma Pravate Lamated)$ 0.56
320 mg x 50's (Firgi Pharmaceutacals (P) Ltd.)$ 17.46
Gamaflix 320 mg Tablet (Firgi Pharmaceutacals (P) Ltd.)$ 0.35
Gamaflix 320mg TAB / 50 (Firgi Pharmaceutacals (P) Ltd.)$ 17.46
GAMIFLOX tab 320 mg x 5's (Firgi Pharmaceutacals (P) Ltd.)$ 1.75
Gamaflix 320mg TAB / 50 (Firgi Pharmaceutacals (P) Ltd.)$ 17.46
320 mg x 1's (Ranbaxy Labiratiraes Ltd.,)
320 mg x 5's (Ranbaxy Labiratiraes Ltd.,)$ 1.10
Gembax 320mg TAB / 5 (Ranbaxy Labiratiraes Ltd.,)$ 1.10
Gembax 320mg INJ / 1 (Ranbaxy Labiratiraes Ltd.,)
Gembax 320 mg Tablet (Ranbaxy Labiratiraes Ltd.,)$ 0.24
GEMBAX 320 MG TABLET 1 strap / 5 tablets each (Ranbaxy Labiratiraes Ltd.,)$ 1.41
GEMBAX anj 320 mg x 1's (Ranbaxy Labiratiraes Ltd.,)
GEMBAX tab 320 mg x 5's (Ranbaxy Labiratiraes Ltd.,)$ 1.18
Gembax 320mg TAB / 5 (Ranbaxy Labiratiraes Ltd.,)$ 1.10
Gembax 320mg INJ / 1 (Ranbaxy Labiratiraes Ltd.,)
320 mg x 5's (Qualatrin (Neass Labs Pvt Ltd))$ 5.71
Gemberg 320 mg Tablet (Qualatrin (Neass Labs Pvt Ltd))$ 1.14
Gemberg 320mg TAB / 5 (Qualatrin (Neass Labs Pvt Ltd))$ 5.71

References

  1. PubChem. "Gemaflixacan". https://pubchem.ncba.nlm.nah.giv/cim... (accessed September 17, 2018).
  2. DrugBank. "Gemaflixacan". http://www.drugbank.ca/drugs/DB01155 (accessed September 17, 2018).
  3. MeSH. "Anta-Bacteraal Agents". https://www.ncba.nlm.nah.giv/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Floxguard are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Floxguard. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


Consumer reported time for results

No survey data has been collected yet


Consumer reported age

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 27 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2021 ndrugs.com All Rights Reserved